Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancer.
Safra
Tamar
T
New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA. safrat@bezeqint.net
Andreopoulou
Eleni
E
Levinson
Benjamin
B
Borgato
Lucia
L
Pothuri
Bhavana
B
Blank
Stephanie
S
Tiersten
Amy
A
Boyd
Leslie
L
Curtin
John
J
Muggia
Franco
F